| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 20, 2017Azure(TM) with BlueSync(TM) Technology Improves Device Longevity and Provides Automatic, Wireless Remote Patient Monitoring
DUBLIN - November 20, 2017 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with...
-
Nov 13, 2017
DUBLIN - November 13, 2017 - Medtronic plc (NYSE: MDT) today announced several noteworthy presentations of clinical studies and symposia on aortic, peripheral, endoVenous, and vascular...
-
Nov 8, 2017Preliminary Revenue of Approximately $7.1 Billion
DUBLIN - November 8, 2017 - Medtronic plc (NYSE: MDT) today announced its preliminary revenue for its second quarter of fiscal year 2018, which ended October 27, 2017. The company announced...
-
Nov 1, 2017DAPT-STEMI Late-Breaker at TCT Reveals Results of Shortened DAPT Duration in Higher-Risk Patients
DUBLIN and DENVER - November 1, 2017 - Investigators today unveiled clinical data from the independently run DAPT-STEMI trial, which found no difference in patient outcomes between six-and...
-
Sep 27, 2017Patients with End-Stage Heart Failure Now Have New Options for Care
DUBLIN - September 27, 2017 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for its HeartWare(TM) HVAD(TM) System as a destination therapy for patients...
-
Sep 14, 2017Athletes from Five Continents Benefitting from Medical Technology Will Showcase Remarkable Spirit at the Medtronic Twin Cities Marathon and Medtronic TC 10 Mile Events This October
DUBLIN - September 14, 2017 - Long distance running is never easy. But for twenty long-distance runners participating in the Medtronic Twin Cities Marathon Weekend, just toeing the starting line...
-
Sep 12, 2017Data Further Reinforce IN.PACT Admiral DCB as Frontline Option to Address Treatment Challenges in PAD
DUBLIN and LAS VEGAS - September 12, 2017 - Medtronic plc (NYSE: MDT) data announced today reinforce the durability and safety of the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in patients...
-
Sep 11, 2017
DUBLIN - September 11, 2017 - Medtronic plc (NYSE:MDT) announced today that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all models...
-
Sep 8, 2017Medtronic Announces Japanese Regulatory Approval for the IN.PACT(TM) Admiral(TM) Drug-Coated BalloonClinically-Proven, Durable, Consistent, and Safe Market-Leading DCB Poised to Improve Outcomes for PAD Patients in Japan
DUBLIN - September 8, 2017 - Medtronic plc (NYSE: MDT) today announced that the IN.PACT(TM)Admiral(TM) Drug-Coated Balloon (DCB) received approval from the Japanese Ministry of Health, Labour and...
-
Sep 7, 2017
DUBLIN - September 7, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 15th Annual Morgan Stanley Global Healthcare...
-
Sep 7, 2017
PORTSMOUTH, N.H., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Medtronic (NYSE:MDT), a global medical device company with offices at the Pease Tradeport in Portsmouth, has been named the Best Company to...
-
Sep 5, 2017
DUBLIN - September 5, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 2017 Wells Fargo Healthcare Conference on Thursday,...
-
Aug 28, 2017Published Simultaneously in The Lancet, the Late-Breaking SPYRAL HTN-OFF MED Study at ESC Successfully Isolates RDN Treatment Effect to Show Compelling Efficacy and Safety of Hypertension Procedure
DUBLIN and BARCELONA - August 28, 2017 - Medtronic plc (NYSE:MDT) today announced its intent to move forward with a new renal denervation pivotal trial following positive first results from a...
-
Aug 22, 2017Revenue of $7.390 Billion Grew 3% as Reported; 4% at Constant Currency
DUBLIN - August 22, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2018, which ended July 28, 2017. The company reported first quarter...
-
Aug 17, 2017
DUBLIN - August 17, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the CFA Society Minnesota's 6th Annual Investor Conference,...
-
Aug 15, 2017
DUBLIN - August 15, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the first quarter fiscal year 2018 on Tuesday, August 22, 2017. A news release will...
-
Aug 2, 2017Introduction of New Pericardial Aortic Heart Valve in the U.S. and Europe Reinforces Company's Commitment to Comprehensive Solutions to Heart Valve Disease
DUBLIN - August 2, 2017 - Medtronic plc (NYSE: MDT) today announced CE (Conformité Européenne) mark and U.S. Food and Drug Administration (FDA) approval of its new Avalus(TM) pericardial aortic...
-
Aug 1, 2017Data from Landmark Trial Published in the Journal of the American Heart Association
DUBLIN - August 1, 2017 - A new health economic analysis from the landmark FIRE AND ICE Trial, sponsored by Medtronic plc (NYSE: MDT), was published today in the Journal of the American Heart...
-
Jul 17, 2017The InterStim System is the Only Proven, Long-Term Sacral Neuromodulation Solution for Overactive Active Bladder
DUBLIN - July 17, 2017 - Medtronic plc (NYSE: MDT) today announced that the InterStim(TM) system, which provides sacral neuromodulation therapy, offers sustained long-term efficacy and quality of...
-
Jun 18, 2017Data Presented as Late Breaking Clinical Trial at EUROPACE 2017
DUBLIN and VIENNA - June 18, 2017 - Continuing its leadership in the detection, reduction, and treatment of atrial fibrillation (AF), Medtronic plc (NYSE: MDT) today announced that its Reactive...
-
Jun 6, 2017Medtronic Will Host a Webcast of Its Diabetes Group Analyst and Investor Briefing on Saturday, June 10 from 2 - 4 p.m. PDT
DUBLIN - June 6, 2017 - Medtronic (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the 77th Scientific Sessions of...
-
May 25, 2017Q4 Revenue of $7.9 Billion Grew 5% as Reported; 5% at Constant Currency
DUBLIN - May 25, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2017, which ended April 28, 2017. The company reported fourth quarter...
-
May 24, 2017
DUBLIN - May 24, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 38th Annual Goldman Sachs Global Healthcare Conference on...
-
May 24, 2017
DUBLIN - May 24, 2017 - Medtronic plc (NYSE: MDT) today announced that the first patient has been enrolled in the IN.PACT(TM) AV Access Drug-Coated Balloon (DCB) study for use in patients with...
-
May 18, 2017First-Ever Study on 2.0 mm DES, EuroPCR Late-Breaking Data Show Exceptional Deliverability and No Stent Thrombosis for the Resolute Onyx DES
DUBLIN and PARIS- May 18, 2017 - Medtronic plc (NYSE: MDT) today announced that the Resolute Onyx(TM) Drug-Eluting Stent (DES) met its primary endpoint of Target Lesion Failure (TLF) at one year...
-
May 16, 2017
DUBLIN - May 16, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 2017 Jefferies Global Healthcare Conference on Thursday, June...
-
May 9, 2017
DUBLIN - May 9, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the fourth quarter and fiscal year 2017 on Thursday, May 25, 2017. A news release will be...
-
Apr 26, 2017Presented at Charing Cross, Five-Year Clinical Data from Global ENGAGE Registry Support Endurant II's Market-Leading Position Worldwide
DUBLIN and LONDON - April 26, 2017 - Medtronic plc (NYSE:MDT) today reported its Endurant® II abdominal aortic aneurysm (AAA) stent graft system continues to demonstrate long-term durability and...
-
Apr 18, 2017
DUBLIN - April 18, 2017 - Medtronic plc (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has classified the company's recently initiated voluntary field action related...
-
Apr 12, 2017Applications now open: www.medtronic.com/globalchampions
DUBLIN - April 12, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced applications are now open for the 2017 Medtronic Global Champions team. Medtronic...
-
Apr 6, 2017
DUBLIN - April 6, 2017 - Medtronic plc (NYSE: MDT) today announced that on February 22, 2017 it notified customers of a voluntary recall of all unused units of the StrataMR(TM) adjustable valves...
-
Apr 6, 2017HVAD(TM) System is a Mechanical Pump that Circulates Blood Throughout the Body in Patients with Advanced Heart Failure.
DUBLIN and SAN DIEGO - April 6, 2017 - Preliminary results from the Medtronic plc (NYSE:MDT)-sponsored HVAD LATERAL(TM) study were presented today as a late breaking clinical trial during the 2017...
-
Apr 5, 2017
GLOBE NEWSWIRE via COMTEX) --Data Presented in Late-Breaking Presentation at ISHLT 2017 DUBLIN and SAN DIEGO - April 5, 2017 - Medtronic plc (NYSE:MDT) today announced results of the ENDURANCE...
-
Apr 5, 2017
DUBLIN - April 5, 2017 - Medtronic (NYSE: MDT) is notifying customers worldwide of a voluntary field corrective action for all its Newport HT70 and Newport HT70 Plus ventilators manufactured since...
-
Mar 24, 2017American College of Cardiology, American Heart Association and Heart Rhythm Society Jointly Issue First-Ever Syncope Guidelines that Reinforce Benefits of Continuous Cardiac Monitoring
DUBLIN - March 24, 2017 - Newly published guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Rhythm Society (HRS) recommend the use of...
-
Mar 21, 2017
GLOBE NEWSWIRE via COMTEX) --DUBLIN - March 21, 2017 - Medtronic plc (NYSE: MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), has priced...
-
Mar 16, 2017
DUBLIN - March 16, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Oppenheimer 27th Annual Healthcare Conference on Tuesday,...
-
Mar 14, 2017Minimally Invasive Procedure Provides More Options for Osteoporotic Fracture Patients Suffering from Pain
DUBLIN - March 14, 2017 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of Kyphon(TM) Xpede Bone Cement for fixation of...
-
Mar 11, 2017
DUBLIN - May 11, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Bernstein 33rd Annual Strategic Decisions Conference on...
-
Mar 3, 2017
DUBLIN - Mar. 3, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Barclays Global Healthcare Conference on Wednesday, March 15,...
-
Feb 27, 2017
DUBLIN - Feb. 27, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual Cowen and Company Healthcare Conference on...
-
Feb 21, 2017Revenue of $7.3 Billion Grew 5% as Reported; 6% at Constant Currency
DUBLIN - February 21, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2017, which ended January 27, 2017. The company reported third quarter...
-
Feb 16, 2017Demonstrated Safe and Effective for Treating Patients with Abnormal Heart Rhythm of AVNRT
DUBLIN - Feb. 16, 2017 - Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has approved its Freezor® Xtra Cryoablation Catheter for treating patients with...
-
Feb 13, 2017
DUBLIN - Feb. 13, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the RBC Capital Markets 2017 Global Healthcare Conference on...
-
Feb 10, 2017
DUBLIN - Feb. 10, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its third quarter of fiscal year 2017 on Tuesday, February 21, 2017. A news release...
-
Feb 9, 2017New Data Recently Presented at LINC 2017 Represents the First Presentation of Clinical Results Comparing a DCB to Angioplasty in Japan
DUBLIN - Feb. 9, 2017 - Medtronic plc (NYSE: MDT) today announced the one-year clinical outcomes from the MDT-2113 IN.PACT SFA Japan Trial. The data was recently presented by Osamu Iida, M.D.,...
-
Jan 26, 2017
DUBLIN - Jan. 26, 2017 - Medtronic plc (NYSE: MDT) today announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a study of the...
-
Jan 25, 2017First Presentation of Results from Regional Cohorts of IN.PACT Global Study Reinforce Strong, Consistent and Safe Outcomes for PAD Patients
DUBLIN and LEIPZIG, Germany - Jan. 25, 2017 - Medtronic today presented new data at the Leipzig Interventional Course (LINC) 2017 conference supporting the IN.PACT® Admiral® drug-coated balloon...
-
Jan 24, 2017
DUBLIN - Jan. 24, 2017 - Medtronic plc (NYSE: MDT) announced today that the first procedure using the Visualase(TM) MRI-Guided Laser Ablation System has been performed in the pivotal SLATE...
-
Jan 3, 2017
DUBLIN - Jan. 3, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 35th Annual J.P. Morgan Healthcare Conference on Monday,...
Dec 21, 2016Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec et risus odio. Vivamus pellentesque, tortor a tempor semper, massa nulla placerat augue, sit amet convallis tellus orci ut massa....
-
Dec 8, 2016
DUBLIN - Dec. 8, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Jefferies 2016 Diabetes Technology Summit on Monday, December...
-
Nov 22, 2016Revenue of $7.3 Billion Grew 4% as Reported; 3% at Constant Currency
DUBLIN - November 22, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2017, which ended October 28, 2016. The company reported second...
-
Nov 17, 2016Data from ANCHOR Registry Demonstrate Applicability in Patients with Hostile Aortic Neck Anatomy
DUBLIN and NEW YORK - Nov. 17, 2016 - Medtronic plc (NYSE: MDT) today announced data demonstrating that the company's Heli-FX(TM) EndoAnchor(TM) system enhances outcomes and durability in patients...
-
Nov 15, 2016New Data from the Global ENGAGE Registry Builds on Durability of Endurant, with Strong Outcomes Out to Four Years in Patients with Standard and Hostile Neck Anatomies
DUBLIN - Nov. 15, 2016 - Medtronic plc (NYSE:MDT) today announced data supporting the strength and durability of the Endurant(TM) II/IIs1 stent graft system to treat abdominal aortic aneurysm...
-
Nov 14, 2016
DUBLIN - Nov. 14, 2016 - Medtronic plc (NYSE: MDT) today announced notable presentations of clinical studies on how endovascular treatments are furthering the treatment of core and complex aortic...
-
Nov 11, 2016
DUBLIN - Nov. 11, 2016 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its second quarter of fiscal year 2017 on Tuesday, November 22, 2016. A news release...
-
Oct 30, 2016BIO-RESORT Demonstrates Excellent Clinical Outcomes for Medtronic Resolute(TM) Integrity(TM) DES, a Gold Standard for Percutaneous Coronary Intervention
DUBLIN and WASHINGTON, DC - Oct. 30, 2016 - Investigators today unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers analysis to compare the safety and...
-
Oct 24, 2016MiniMed Connect Mobile Accessory Provides Easier and Better Access to Pump and CGM Data, Helping Optimize Therapy for Improved Glycemic Patterns
DUBLIN - October 24, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. commercial availability of the Android(TM) operating system version of the...
-
Oct 21, 2016
DUBLIN - Oct. 21, 2016 - Medtronic plc (NYSE:MDT) today announced the company will webcast investor and analyst briefings at two upcoming medical conferences. Medtronic will host a webcast to...
-
Oct 14, 2016
DUBLIN - Oct. 14, 2016 - Medtronic plc (NYSE: MDT) today announced that it has notified customers of a voluntary recall of certain lots of its Pipeline(TM) embolization device, Alligator(TM)...
-
Oct 13, 2016Late Breaking Clinical Trial Demonstrates Favorable Health Economics and Positive Clinical Outcomes for AF Patients
DUBLIN AND SEOUL, REPUBLIC OF KOREA - Oct. 13, 2016 - Medtronic plc (NYSE:MDT) today unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon catheter ablation...
-
Oct 3, 2016Presented at EACTS, First Data of New Pericardial Heart Valve Finds High Survival and Excellent Hemodynamics
DUBLIN and BARCELONA - Oct. 3, 2016 - Medtronic plc (NYSE: MDT) today announced positive clinical data for its investigational Avalus(TM) pericardial aortic surgical valve, intended for the...
-
Sep 30, 2016
DUBLIN - Sept. 30, 2016 - Medtronic plc (NYSE:MDT) announced today that two previously communicated global voluntary recalls related to the HeartWare International (HeartWare) HVAD® System have...
-
Sep 27, 2016Sugar.IQ with Watson Cognitive App to Preview at Health 2.0 Conference
DUBLIN and SANTA CLARA, Calif. - Sept. 27, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that Sugar.IQ with Watson, the first-of-its-kind cognitive app...
-
Sep 19, 2016Multiple, Rigorous Analyses Reinforce the Excellent Outcomes of IN.PACT Admiral Drug Coated Balloon and Differentiate it as Best-in-Class Treatment Option for PAD
DUBLIN and LAS VEGAS - September 19, 2016 - Medtronic today reinforced the superior durability, consistency, and safety of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral...
-
Sep 6, 2016
DUBLIN - Sept. 6, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that it will participate in the Morgan Stanley Global Healthcare...
-
Sep 1, 2016
DUBLIN - Sept. 1, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that it will participate in the Wells Fargo Global Healthcare...
-
Aug 25, 2016Revenue of $7.2 Billion Decreased 1% as Reported; Prior Year Had Extra Selling Week
DUBLIN - August 25, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2017, which ended July 29, 2016. The company reported first quarter...
-
Aug 16, 2016
DUBLIN - Aug 16, 2016 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the first quarter of fiscal year 2017, on Thursday, August 25, 2016. A news release will...
-
Aug 11, 2016
DUBLIN - August 11, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. commercial launch of its MiniMed 630G system with SmartGuard technology FDA...
-
Jul 28, 2016New Service Integrates Medtronic Device Data with Remote Patient Monitoring Solutions
DUBLIN - June 28, 2016 - Medtronic plc (NYSE:MDT) today announced availability of its Beacon Heart Failure Management Service in the United States. This new service from Medtronic Care Management...
-
Jul 28, 2016- Global revenue increased approximately 25% from first quarter of 2016
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Jul 19, 2016New Guardian(TM) Connect System Will Be Launched in Q2 FY17 Outside the U.S.
DUBLIN - July 19, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité Européenne) Mark for its new Guardian(TM) Connect...
-
Jul 18, 2016Two-Level Use of Prestige LP Cervical Disc Exhibited Statistical Superiority in Overall Success at 24 Months Compared to Patients Treated with Two-Level Fusion
DUBLIN - July 18, 2016 - Medtronic plc (NYSE: MDT) announced today the U.S. Food and Drug Administration's (FDA) approval of the Prestige LP(TM) Cervical Disc for the treatment of cervical disc...
-
Jul 15, 2016International Award Honors the Philanthropic Power of Patients; At Least 10 Honorees Will Each Receive a $20,000 Grant Donated to an Eligible Charity Organization of Their Choice
DUBLIN - July 15, 2016 - The Medtronic Foundation is seeking applications for the 2016 Bakken Invitation Award - an international program honoring and connecting people who have overcome health...
-
Jun 17, 2016Drug-Resistant Mesial Temporal Lobe Epilepsy Is the Focus of Medtronic's SLATE Study
DUBLIN - June 17, 2016 - Medtronic plc (NYSE: MDT) announced today the U.S. Food and Drug Administration's (FDA) approval of the Investigational Device Exemption (IDE) application for the pivotal...
-
Jun 10, 2016Secondary Analyses Presented at Cardiostim 2016 Highlight Positive, Real-World Patient Outcomes
DUBLIN AND NICE, FRANCE - June 10, 2016 - Medtronic plc (NYSE: MDT) today announced findings from the secondary analyses of the FIRE AND ICE clinical trial that demonstrate significantly fewer...
-
Jun 10, 2016CareLink® Portfolio Updates, IBM Watson Partnership Progress and New Strategic Alliances Delivering Intelligent Data and Actionable Information at ADA 2016
DUBLIN and NEW ORLEANS - June 10, 2016 - Delivering on its vision to transform care for the millions currently living with diabetes through intelligent data, Medtronic plc (NYSE:MDT) announced new...
-
Jun 7, 2016
DUBLIN - June 7, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the 76th Scientific Sessions...
-
Jun 6, 2016
DUBLIN and NEW YORK CITY - June 6, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, shared during its Investor Day today in New York City an overview of the company's...
-
May 31, 2016Q4 Revenue of $7.6 Billion Grew 4% as Reported; 6% at Constant Currency
DUBLIN - May 31, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2016, which ended April 29, 2016. The company reported fourth quarter...
-
May 17, 2016
DUBLIN - May 17, 2016 -Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that it will participate in the 37th Annual Goldman Sachs Global...
-
May 11, 2016
DUBLIN - May 11, 2016 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the fourth quarter and fiscal year 2016, on Tuesday, May 31, 2016. A news release will...
-
May 11, 2016Medtronic and the Vikings to Unveil "The Horn" Monument on Medtronic Plaza Outside U.S. Bank StadiumNew 38-Ton Artistic Landmark Represents the Spirit of Progress and Partnership That Together Lead Our Community to a Better Future
MINNEAPOLIS - May 11, 2016 - Medtronic plc (NYSE: MDT) and the Minnesota Vikings today announced Medtronic's contribution of a new contemporary art sculpture on Medtronic Plaza, just outside the...
-
May 10, 2016
DUBLIN - May 10, 2016 - Medtronic plc (NYSE:MDT) announced today that the company will host its biennial Institutional Investor and Analyst Meeting on Monday, June 6, 2016, in New York City from...
-
May 7, 2016
DUBLIN - May 17, 2016 -Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that the company will participate in the Jefferies 2016 Healthcare...
-
May 4, 2016-- First quarter 2016 revenue of $55 million reflects lower year-over-year clinical trial revenue and competitive dynamics --
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
May 3, 2016Study Represents Longest Patient Follow-Up Data for U.S. 2-Level Cervical Disc Patients
DUBLIN and CHICAGO - May 3, 2016 - Medtronic plc (NYSE: MDT) today announced results of seven-year follow-up data demonstrating favorable clinical outcomes and patient satisfaction for the 2-level...
-
May 1, 2016Potentially Reaching More Patients at Risk for Colon Cancer
DUBLIN - March 31, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) cleared PillCam(TM) COLON 2 capsule for an expanded indication for use. The...
-
Apr 30, 2016New Data at ACC.16 First to Show Superior, Longer-Term Outcomes for Self-Expanding TAVR vs. SAVR at Three Years Results Published Simultaneously in the Journal of American College of Cardiology (JACC)
DUBLIN and CHICAGO - April 3, 2016 - Medtronic plc (NYSE: MDT) today announced new data from the High Risk Study of the CoreValve U.S. Pivotal Trial that show superior clinical outcomes for...
-
Apr 27, 2016- Clinical Trial Evaluates Less-Invasive Thoracotomy Implant Technique of the HVAD System in Patients with Advanced Heart Failure -
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Apr 20, 2016- HeartWare to Host Scientific Symposiums on HVAD System Waveforms and Advancements in HVAD System Outcomes -
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Apr 20, 2016
DUBLIN - April 20, 2016 - Medtronic is notifying customers worldwide of a voluntary recall for the battery pack used in its Covidien Oridion labeled Capnostream(TM)20 and Capnostream(TM)20p...
-
Apr 14, 2016
DUBLIN - April 14, 2016 - Medtronic plc (the "Company") (NYSE: MDT) today announced that, pursuant to the previously-announced cash tender offer by its wholly-owned subsidiaries, Medtronic, Inc....
-
Apr 14, 2016
DUBLIN - April 14, 2016 - Medtronic plc (the "Company") (NYSE: MDT) today announced the pricing terms of the previously-announced cash tender offer by its wholly-owned subsidiaries, Medtronic, Inc. ("
-
Apr 4, 2016Cryoballoon Comparable in Safety and Effectiveness as Current Standard of Care Ablation Technology
DUBLIN and CHICAGO - April 4, 2016 - Medtronic plc (NYSE: MDT) today announced positive results from the landmark FIRE AND ICE clinical trial, which demonstrated comparable safety and...
-
Mar 31, 2016
DUBLIN - March 31, 2016 - Medtronic plc (the "Company") (NYSE: MDT) today announced the commencement of a cash tender offer (the "Tender Offer") by its wholly-owned subsidiaries, Medtronic, Inc....
-
Mar 29, 2016Medtronic Foundation Seeks Runners Benefitting from Medical Technology for 2016 "Global Heroes" TeamApplications now open: www.medtronic.com/globalheroes
DUBLIN - March 29, 2016 - Applications are now open for the 2016 Global Heroes running team. Every October since 2006, the Medtronic Foundation and Twin Cities In Motion have brought people from...
-
Mar 4, 2016
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...